We are monitoring the impact of COVID-19 & Recession alarm on MEA Tissue Diagnostics Market Get in touch with us for detailed analysis Know More

Know More

Share on

Middle East and Africa Tissue Diagnostics Market Research Report - Segmented By Product Type, Application, End User, Disease & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 4095
Pages: 130

MEA Tissue Diagnostics Market Size (2022 to 2027)

The Middle East and Africa Tissue diagnostics Market size is predicted to be USD 234.08 million in 2022. It is further estimated to be growing at a CAGR of 6.4% and value USD 319.21 million by 2027.

Due to the rising cancer incidence and prevalence, increased use of cancer diagnosis, and enhanced cancer detection healthcare infrastructure, the Middle East and Africa tissue diagnostics market is booming. A rising number of industry actors are attempting to improve advanced tissue-diagnostics-based companion tests, which is good for business. An increase in cancer incidence rates and the increased usage of automated tissue diagnostics to diagnose diseases are projected to drive the Middle East and Africa tissue diagnostics market.

As the incidence of cancer, healthcare costs, and spending on cancer research and drug development all rise, the Middle East and Africa tissue diagnostics market is predicted to expand. Furthermore, increased lifestyle changes, rising food and tobacco use, and increased alcohol and common lifestyle disorders are expected to boost market demand in the Middle East and Africa. In addition, the growing number of government programs to raise awareness about the importance of early cancer detection is expected to propel the tissue diagnostics market forward. The Middle East and Africa tissue diagnostics markets are also likely to rise in response to the world's aging population.

Additionally, factors such as increased investments in new technology research and development, the emergence of efficient and accurate products, growing demand for personalized medicines, and untapped market potential due to a lack of efficient diagnostics tests for non-small lung cancer detection are expected to provide lucrative opportunities for tissue diagnostics market growth in this region. Furthermore, demand for tissue diagnostics is likely to increase as healthcare institutions grow in size.

Stringent regulations for the approval of new products and instruments that are highly expensive, lack of access to healthcare indicators in underdeveloped countries, and social stigma associated with cancer are all factors that limit the growth of the Middle East and Africa tissue diagnostics market. Furthermore, rural communities are less aware of new medical innovations, which modestly impacts the Middle East and Africa market demand.

On March 19, 2020, the World Health Organization (WHO) proclaimed a pandemic crisis. Due to the shutdown of production facilities, a scarcity of raw materials, and a lack of workforce, the healthcare market's research and development show a sharp drop in sales during the lockdown. Tissue diagnostics are explicitly employed in cancer patients. Acute coronavirus infection is very common in cancer patients. Therefore, diagnostic labs have been significantly impacted, particularly those examining cell and tissue samples.

This research report on the Middle East and Africa tissue diagnostics market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Instruments
  • Consumables

By Application: 

  • Immunohistochemistry
  • Hematoxylin and Eosin
  • In Situ Hybridization

By End User: 

  • Contract Research Organizations
  • Hospitals
  • Diagnostic Laboratories
  • Research Organizations
  • Biotechnology Companies

By Disease: 

  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Breast Cancer
  • Others

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East and Africa market is predicted to grow at a moderate growth rate throughout the forecast period due to increased attention from government and private sectors in developing countries such as Saudi Arabia, the United Arab Emirates, Israel, and the rest of MEA. In addition, as a result of people's unhealthy lifestyles, cancer incidence is increasing each year, boosting the market for tissue-based diagnosis.

For example, Saudi Arabia, the United Arab Emirates, and Israel are fast-growing economies in the Middle East and Africa. The region's market growth is due to the growing healthcare sector and active key market players. In addition, personalized medicine has expanded dramatically as sequencing technologies and healthcare IT systems have become more widely used in clinical workflows, which is expected to drive the Tissue Diagnostics market in the area.

The tissue diagnostics market in Saudi Arabia is predicted to grow significantly over the forecast period. Saudi Arabia's market expansion is encouraged by the factors such as increased healthcare spending, expanding cancer diagnostic facilities, and government support.

Israel is expected to lead the Middle East and Africa Tissue Diagnostics market. The country's market growth is influenced by the availability of healthcare infrastructure, accessibility to healthcare facilities, and advancements in healthcare technology.

KEY MARKET PLAYERS:

Companies that have a presence in the MEA Tissue diagnostics Market profiled in this report are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology, and Ventana Medical Systems.

1. Introduction            

                1.1 Market Definition            

                1.2 Study Deliverables          

                1.3 Base Currency, Base Year and Forecast Periods     

                1.4 General Study Assumptions        

2. Research Methodology        

                2.1 Introduction          

                2.2 Research Phases 

  2.2.1 Secondary Research   

  2.2.2 Primary Research   

  2.2.3 Econometric Modelling   

  2.2.4 Expert Validation    

                2.3 Analysis Design    

                2.4 Study Timeline     

3. Overview    

                3.1 Executive Summary        

                3.2 Key Inferences    

                3.3 Epidemology         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 

                4.1 Market Drivers     

                4.2 Market Restraints            

                4.3 Key Challenges    

                4.4 Current Opportunities in the Market         

5. Market Segmentation           

                5.1 Product type         

  5.1.1 Introduction   

  5.1.2 Instruments   

        5.1.2.1 Microscope                         

        5.1.2.2 Non-contact Handheld IR Thermometer                

        5.1.2.3 Haemocytometer                             

        5.1.2.4 NMR Tube                           

        5.1.2.5 Others                   

  5.1.3 Consumables 

        5.1.3.1 Reagent kits                        

        5.1.3.2 Others                   

  5.1.4  Y-o-Y Growth Analysis, By Product type 

  5.1.5  Market Attractiveness Analysis, By Product type    

  5.1.6  Market Share Analysis, By Product type 

                5.2 Disease   

  5.2.1 Introduction   

  5.2.2 Lung cancer    

  5.2.3 Lymphoma      

  5.2.4 Pancreatic cancer   

  5.2.5 Breast cancer 

  5.2.6 Others   

  5.2.7 Y-o-Y Growth Analysis, By Disease  

  5.2.8 Market Attractiveness Analysis, By Disease      

  5.2.9 Market Share Analysis, By Disease 

                5.3 Application         

  5.3.1 Introduction   

  5.3.2 Hematoxylin and Eosin   

  5.3.3 Immunohistochemistry  

  5.3.4 In Situ Hybridization    

  5.3.5 Y-o-Y Growth Analysis, By Application 

  5.3.6  Market Attractiveness Analysis, By Application   

  5.3.7  Market Share Analysis, By Application    

                5.4 End user 

  5.4.1 Introduction   

  5.4.2 Hospitals    

  5.4.3 Diagnostic laboratories   

  5.4.4 Research Organizations  

  5.4.5 Contract Research Organizations

  5.4.6 Biotechnology Companies  

  5.4.7 Y-o-Y Growth Analysis, By End user      

  5.4.8  Market Attractiveness Analysis, By End user   

  5.4.9  Market Share Analysis, By End user    

6. Geographical Analysis           

                6.1 Introduction          

  6.1.1 Regional Trends 

  6.1.2 Impact Analysis  

  6.1.3 Y-o-Y Growth Analysis

        6.1.3.1 By Geographical Area                     

        6.1.3.2 By Product type                

        6.1.3.3 By Disease                           

        6.1.3.4 By Application                    

        6.1.3.5 By End user                         

  6.1.4  Market Attractiveness Analysis  

        6.1.4.1 By Geographical Area                     

        6.1.4.2 By Product type                

        6.1.4.3 By disease                           

        6.1.4.4 By Application                    

        6.1.4.5 By End user                         

  6.1.5  Market Share Analysis   

        6.1.5.1 By Geographical Area                     

        6.1.5.2 By Product type                

        6.1.5.3 By Disease                           

        6.1.5.4 By Application                    

        6.1.5.5 By End user                         

                6.2 Middle-East           

                6.3 Africa       

7. Strategic Analysis    

                7.1 PESTLE analysis    

  7.1.1 Political  

  7.1.2 Economic   

  7.1.3 Social 

  7.1.4 Technological 

  7.1.5 Legal  

  7.1.6 Environmental    

                7.2 Porter’s Five analysis         

  7.2.1 Bargaining Power of Suppliers

  7.2.2 Bargaining Power of Consumers 

  7.2.3 Threat of New Entrants  

  7.2.4 Threat of Substitute Products and Services      

  7.2.5 Competitive Rivalry within the Industry  

8. Market Leaders' Analysis     

                8.1 F. Hoffmann-La Roche AG            

  8.1.1 Overview   

  8.1.2 Product Analysis

  8.1.3 Financial analysis    

  8.1.4 Recent Developments    

  8.1.5 SWOT analysis    

  8.1.6 Analyst View  

                8.2 Sigma-Aldrich Co. LLC        

                8.3 Abbott Laboratories       

                8.4 Agilent Technologies         

                8.5 BioGenex            

                8.6 Danaher Corporation        

                8.7 Cell Signaling Technology 

                8.8  Ventana Medical Systems           

9. Competitive Landscape        

                9.1 Market share analysis       

                9.2 Merger and Acquisition Analysis  

                9.3 Agreements, collaborations and Joint Ventures    

                9.4 New Product Launches    

10. Market Outlook and Investment Opportunities      

Appendix        

                a) List of Tables        

                b) List of Figures         

 

  1. Middle East and Africa Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
  2. Middle East and Africa Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  3. Middle East and Africa Consumables Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East and Africa Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
  5. Middle East and Africa Lung cancer Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East and Africa Lymphoma Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East and Africa Pancreatic cancer Market, By Region, From 2022 - 2027 (USD Billion)
  8. Middle East and Africa Breast cancer Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East and Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East and Africa Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
  11. Middle East and Africa Hematoxylin and Eosin Market, By Region, From 2022 - 2027 (USD Billion)
  12. Middle East and Africa Immunohistochemistry Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East and Africa In Situ Hybridization Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East and Africa Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
  15. Middle East and Africa Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  16. Middle East and Africa Diagnostic laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  17. Middle East and Africa Research Organizations Market, By Region, From 2022 - 2027 (USD Billion)
  18. Middle East and Africa Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Billion)
  19. Middle East and Africa Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Billion)
  20. Middle East Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
  21. Middle East Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
  22. Middle East Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
  23. Middle East Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
  24. Africa Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
  25. Africa Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
  26. Africa Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
  27. Africa Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
  28. Middle East and Africa Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
  29. Middle East and Africa Microscope Market, By Region, From 2022 - 2027 (USD Billion)
  30. Middle East and Africa Non-contact Handheld IR Thermometer Market, By Region, From 2022 - 2027 (USD Billion)
  31. Middle East and Africa Haemocytometer Market, By Region, From 2022 - 2027 (USD Billion)
  32. Middle East and Africa NMR Tube Market, By Region, From 2022 - 2027 (USD Billion)
  33. Middle East and Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  34. Middle East Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
  35. Africa Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample